Posted in | News | Laser | Medical Optics

SPI Lasers Announces New Investments in Facilities, Equipment and Personnel

SPI Lasers, a leading designer and manufacturer of fiber lasers, today announced new investments in facilities, equipment and personnel with respect to fiber laser applications development.

Current market conditions look set to increase the penetration of fiber lasers into material processing applications as the lasers are seen as having lower operational costs whilst offering improved processing, with associated reductions in cycle time and scrap, across a wide range of applications. Perfect laser tools in fact for today’s difficult market conditions.

The investment process starts with the appointment of two laser industry experts for the US facility. Mark Brodsky is appointed as Applications Lab Manager (US) and Kevin Ham to Senior Laser Applications Engineer (US) and an expansion of the Applications Lab in Santa Clara, US.

Mark brings with him a wealth of laser applications knowledge and experience which has been gained through his positions as Owner and Founder of LMco Laser Marks Company, Founder and President of Mr Laser Inc. as well as positions within Advanced Micro Devices, Zilog Semiconductor and National Semiconductor Corporation. In addition to his career positions Mark has a host of Technical publications and patents under his belt. Kevin joins SPI’s applications team with over 25 years knowledge in lasers in manufacturing applications and engineering most recently from the medical sector.

In addition to the US senior appointments, SPI has also developed its global applications presence by reinforcing its leading position with a new applications lab in the UK and forging close ties with a number of leading application research centers around the globe

David Parker, CEO of SPI Lasers added "Our applications strategy has enabled us to focus on where we want to be. By making new appointments to our Apps team we have ensured we achieve not only our own internal goals but also those of our existing and future customers. Making additional capital spend on expanding our existing lab in the US, a new lab based in the UK, co-located with our R&D facilities, and forging closer ties with internationally renowned organisations enables us to compete on a global scale with the most advanced technology and most influential/ground breaking organisations behind us."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.